NCT02218892

Brief Summary

Purpose and aims The general aim of this project is to improve the diagnostic methods for disease activity and identify predictive factors (clinical and radiographic factors, pro- and anti-inflammatory mediators in saliva and plasma) for temporomandibular joint (TMJ) involvement in juvenile idiopathic arthritis (JIA). The hypothesis is that self-reported pain and impaired jaw function together with clinical findings correlates well with radiological signs of jaw involvement. Null hypothesis: Self-reported pain, impaired jaw function and clinical findings do not correlate with radiological signs of jaw involvement. Study 1 The aim of this study is to investigate which findings from the patient history and from clinical examination that is of significance for diagnostics of TMJ involvement in patients with JIA both in a short- and long-term perspective. The patients will be followed-up during two years. They will undergo a clinical examination according to Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD; Dworkin and LeResche 1992) once a year and a telephone follow-up sixth months after the clinical examination. Further, the clinical findings from the orofacial regions will be compared to their general disease activity. Study 2 The aim of the second study is to correlate radiological findings and clinical findings in order to investigate any early radiological signs of disease activity and progression but also to compare the radiographic examination using conventional panoramic technique with computer tomography (CT).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
62

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2011

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

June 30, 2014

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 18, 2014

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
6.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

March 6, 2023

Status Verified

March 1, 2023

Enrollment Period

6.5 years

First QC Date

June 30, 2014

Last Update Submit

March 3, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Clinical findings in children with JIA

    To find similarities in patients with JIA according to RDC-TMD (a clinical protocol validated for children)

    2 years

  • Radiographic findings in children with JIA

    Repeated radiographic examination

    Two years

  • Patient history

    Repeated interview on function and pain in the jaw area

    Two years

Study Arms (1)

Juvenil Idiopathic Arthritis

The group consists of children age 7-14 with an diagnosis of active Juvenile Idiopathic Arthritis.

Eligibility Criteria

Age7 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

One-hundred consecutive patients with active JIA, as diagnosed by the Department of Pediatric Rheumatology, Astrid Lindgrens Barnsjukhus, Karolinska University Hospital will be included.

You may qualify if:

  • age between 7 and 14 years
  • a diagnosis of JIA according to the International League of Associations for rheumatology (ILAR) The parents of the patients and/or the patients will give their verbal and written informed consent to participate in the study according to the permission from the regional ethical committee 2011/2:1.

You may not qualify if:

  • current malignancies
  • TMJ surgery or trauma within two years
  • recent intra-articular glucocorticoid injection in TMJ (within 1 month)
  • other conditions or diseases than JIA that may cause orofacial pain.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Folktandvården Stockholmslän AB

Stockholm, 14463, Sweden

Location

Biospecimen

Retention: SAMPLES WITH DNA

whole blood, serum,saliva

MeSH Terms

Conditions

Arthritis, Juvenile

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Britt Hedenberg Magnusson, PhD DDS

    Karolinska Institutet

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
DDS, PhD-student

Study Record Dates

First Submitted

June 30, 2014

First Posted

August 18, 2014

Study Start

February 1, 2011

Primary Completion

August 1, 2017

Study Completion

December 1, 2023

Last Updated

March 6, 2023

Record last verified: 2023-03

Locations